New technology could lead to development of novel "xenoprotein" drugs against infectious diseases

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits

Siemens has begun working on infrastructure improvements for the University of Maryland’s Institute for Bioscience & Biotechnology Research (IBBR) campus in Rockville

The new technology has biomedical, soft robot and other applications

Researchers have found that when triclosan is combined with an antibiotic called tobramycin, it kills cells that protect cystic fibrosis bacteria by up to 99.9 percent

It is commonly accepted that group sizes of animals increase when there is a risk of predation, since larger group sizes reduce the risk of individuals being killed

Researchers have identified a new potential target to fight acute myeloid leukemia

Agroforestry systems hold the promise for sustainable cocoa cultivation

Protein "proofreading" errors lead to neurodegenerative disease

Study results reveal three major waves of migration

This vision of simplifying disease diagnosis using topically-applied nanotechnology could change the way skin diseases are diagnosed and managed

Columbia Engineering team discovers the fibers' exceptional capabilities to reflect sunlight and transmit optical signals and images